REPLIGEN CORP Restructuring Reserve
REPLIGEN CORP (RGEN) had Restructuring Reserve of $2.07 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2026-07-29
- 2026-06-30: Restructuring Reserve $2.07M.
- 2026-03-31: Restructuring Reserve $908.00K.
- 2025-12-31: Restructuring Reserve $147.00K; Restructuring Reserve as first filed $0.00.
- 2025-09-30: Restructuring Reserve $0.00.
| Period end | Restructuring Reserve | Restructuring Reserve as first filed |
|---|---|---|
| 2026-06-30 | $2.07M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $908.00K 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $147.00K 10-Q · filed 2026-07-29 | $0.00 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $425.00K 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $516.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $196.00K 10-Q · filed 2024-11-18 | |
| 2024-06-30 | $639.00K 10-Q/A · filed 2024-11-18 | |
| 2024-03-31 | $767.00K 10-Q/A · filed 2024-11-18 | |
| 2023-12-31 | $464.00K 10-K/A · filed 2024-11-18 | |
| 2023-09-30 | $138.00K 10-Q/A · filed 2024-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |